ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway |
Sun, Tong
(Department of Nuclear Medicine, The first Hospital of China Medical University)
Du, Bulin (Department of Nuclear Medicine, The first Hospital of China Medical University) Diao, Yao (Department of Nuclear Medicine, The first Hospital of China Medical University) Li, Xuena (Department of Nuclear Medicine, The first Hospital of China Medical University) Chen, Song (Department of Nuclear Medicine, The first Hospital of China Medical University) Li, Yaming (Department of Nuclear Medicine, The first Hospital of China Medical University) |
1 | Siegel RL, Miller KD and Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68, 277-300 |
2 | Coudray N, Moreira AL, Sakellaropoulos T, Fenyo D, Razavian N and Tsirigos A (2018) Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med 24, 1559-1567 DOI |
3 | Yamasaki T, Nakazaki Y, Yoshida M and Watanabe Y (2011) Roles of conserved arginines in ATP-binding domains of AAA+ chaperone ClpB from Thermus thermophiles. FEBS J 278, 2395-2403 DOI |
4 | Nouet C, Truan G, Mathieu L and Dujardin G (2009) Functional analysis of yeast bcs1 mutants highlights the role of Bcs1p-specific amino acids in the AAA domain. J Mol Biol 388, 252-261 DOI |
5 | Zou JX, Revenko AS, Li LB, Gemo AT and Chen HW (2007) ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci U S A 104, 18067-18072 DOI |
6 | Zheng L, Li T, Zhang Y et al (2015) Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer. Oncol Rep 33, 2337-2344 DOI |
7 | Fouret R, Laffaire J, Hofman P et al (2012) A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma. Clin Cancer Res 18, 5606-5616 DOI |
8 | Alvarez JV, Belka GK, Pan T et al (2014) Oncogene pathway activation in mammary tumors dictates [18F]-FDG-PET uptake. Cancer Res 74, 7583-7598 DOI |
9 | Zhang Y, Sun Y, Li Y et al (2013) ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma. Ann Surg Oncol 20, 577-582 DOI |
10 | Fan Y, Dickman KG, Zong WX (2010) Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem 285, 7324-7333 DOI |
11 | Caron C, Lestrat C, Marsal S et al (2010) Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 29, 5171-5181 DOI |
12 | Zhang MJ, Zhang CZ, Du WJ, Yang XZ and Chen ZP (2015) ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker. Clin Transl Oncol 18, 1-6 DOI |
13 | Wu G, Liu H, He H et al (2014) miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis. BMC Cancer 14, 1-11 DOI |
14 | Wan WN, Zhang YX, Wang XM et al (2014) ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis. APJCP 15, 2777-2783 |
15 | Shang P, Meng FL, Liu YD and Chen XW (2015) Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis. Tumor Biol 36, 4479-4485 DOI |
16 | Jadvar H, Alavi A, Gambhir SS (2009) [18F]FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 50, 1820-1827 DOI |
17 | Cho H, Lee YS, Kim J, Chung JY and Kim JH (2013) Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cancer Invest 31, 607-615 DOI |
18 | Chae YC and Kim JH (2018) Cancer stem cell metabolism: target for cancer therapy. BMB Rep 51, 319-326 DOI |
19 | Zhuo B, Li Y, Li Z et al (2015) PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma. Biochem Biophys Res Commun 464, 401-406 DOI |
20 | Wang H, Wang L, Zhang YJ, Wang J, Deng YB and Lin DG (2016) Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int 16, 9 DOI |
21 | Wahlstrom T and Henriksson MA (2015) Impact of MYC in regulation of tumor cell metabolism. Biochim Biophys Acta 1849, 563-569 DOI |
22 | Boussouar F, Jamshidikia M, Morozumi Y, Rousseaux S and Khochbin S (2013) Malignant genome reprogramming by ATAD2. Biochim Biophys Acta 1829, 1010-1014 DOI |
23 | Wu K, Wang W, Chen H, Gao W and Yu C (2019) Insulin promotes proliferation of pancreatic ductal epithelial cells by increasing expression of PLK1 through PI3K/AKT and NF-kB pathway. Biochem Biophys Res Commun 509, 925-930 DOI |
24 | Tsai JS, Chao CH and Lin LY (2016) Cadmium activates multiple signaling pathways that coordinately stimulate Akt activity to enhance c-Myc mRNA stability. PLoS One 11, e0147011 DOI |
25 | Hong SY, Yu FX, Luo Y and Hagen T (2016) Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Cell Signal 28, 377-383 DOI |
26 | Stine ZE, Walton ZE, Altman BJ, Hsieh AL and Dang CV (2015) MYC, metabolism, and cancer. Cancer Discov 5, 1024-1039 DOI |
27 | Ciro M, Prosperini E, Quarto M et al (2009) ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res 69, 8491-8498 DOI |
![]() |